Ethionamide is a second-line antitubercular agent that inhibits mycolic acid synthesis, disrupting the bacterial cell wall. It is used in research involving drug-resistant Mycobacterium tuberculosis, with applications in both in vitro susceptibility testing and in vivo animal models of tuberculosis infection.